Guardian Pharmacy Services, Inc. (GRDN)
NYSE · Retail-Drug Stores and Proprietary Stores · Inc. GA
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 1 signal for Guardian Pharmacy Services, Inc.. Most notable: 2026-06-22: Filed 8-K disclosing director or officer change. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Large insider saleBindley Capital Partners I, LLC (ten_percent_owner) sold $106.0M of stock
- Large insider saleSalentine Thomas J Jr (director) sold $106.0M of stock
- Large insider saleBINDLEY WILLIAM E (director) sold $106.0M of stock
- Large insider salePharmacy Investors, LLC (other) sold $24.6M of stock
- Large insider saleAckerman John (director) sold $24.6M of stock
- Large insider saleBurke Fred (director) sold $19.9M of stock
- Large insider saleForbes Kendall (officer) sold $10.3M of stock
- Large insider saleAckerman John (director) sold $8.2M of stock
- Large insider saleCardinal Equity Fund, L.P. (other) sold $8.2M of stock
- Large insider saleMorris David K (director) sold $5.6M of stock
- Insider purchaseCOSLER STEVEN D (director) bought $100k of stock
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-05 | LEWIS RANDALL J | director | A | 4,028 | 0 | $0 |
| 2026-05-05 | Patchett Mary Sue | director | A | 4,028 | 0 | $0 |
| 2026-05-05 | COSLER STEVEN D | director | A | 4,028 | 0 | $0 |
| 2026-05-05 | Patchett Mary Sue | director | A | 4,028 | 0 | $0 |
| 2026-05-05 | COSLER STEVEN D | director | A | 4,028 | 0 | $0 |
| 2026-05-05 | LEWIS RANDALL J | director | A | 4,028 | 0 | $0 |
| 2026-03-28 | Burke Fred | director | M | 1,298,826 | — | — |
| 2026-03-28 | Ackerman John | director | M | 471,057 | — | — |
| 2026-03-28 | Ackerman John | director | M | 1,413,939 | — | — |
| 2026-03-28 | Salentine Thomas J Jr | director | M | 6,100,175 | — | — |
| 2026-03-28 | Bindley Capital Partners I, LLC | ten percent owner | M | 6,100,175 | — | — |
| 2026-03-28 | Morris David K | director | M | 641,869 | — | — |
| 2026-03-28 | Cardinal Equity Fund, L.P. | other | M | 471,057 | — | — |
| 2026-03-28 | Forbes Kendall | officer | M | 608,570 | — | — |
| 2026-03-28 | BINDLEY WILLIAM E | director | M | 6,100,175 | — | — |
| 2026-03-28 | Pharmacy Investors, LLC | other | M | 1,413,939 | — | — |
| 2026-03-28 | Pharmacy Investors, LLC | other | M | 1,413,939 | — | — |
| 2026-03-28 | BINDLEY WILLIAM E | director | M | 6,100,175 | — | — |
| 2026-03-28 | Cardinal Equity Fund, L.P. | other | M | 471,057 | — | — |
| 2026-03-28 | Salentine Thomas J Jr | director | M | 6,100,175 | — | — |
| 2026-03-28 | Forbes Kendall | officer | M | 608,570 | — | — |
| 2026-03-28 | Morris David K | director | M | 641,869 | — | — |
| 2026-03-28 | Bindley Capital Partners I, LLC | ten percent owner | M | 6,100,175 | — | — |
| 2026-03-28 | Ackerman John | director | M | 1,413,939 | — | — |
| 2026-03-28 | Ackerman John | director | M | 471,057 | — | — |
| 2026-03-28 | Burke Fred | director | M | 1,298,826 | — | — |
| 2026-03-20 | BINDLEY WILLIAM E | director | S | 3,570,677 | 29.68 | $105,986,620 |
| 2026-03-20 | Ackerman John | director | S | 275,728 | 29.68 | $8,184,296 |
| 2026-03-20 | Ackerman John | director | S | 827,636 | 29.68 | $24,566,306 |
| 2026-03-20 | Bindley Capital Partners I, LLC | ten percent owner | S | 3,570,677 | 29.68 | $105,986,620 |
| 2026-03-20 | Salentine Thomas J Jr | director | S | 3,570,677 | 29.68 | $105,986,620 |
| 2026-03-20 | Cardinal Equity Fund, L.P. | other | S | 275,728 | 29.68 | $8,184,296 |
| 2026-03-20 | Forbes Kendall | officer | S | 346,672 | 29.68 | $10,290,092 |
| 2026-03-20 | Burke Fred | director | S | 671,432 | 29.68 | $19,929,780 |
| 2026-03-20 | Morris David K | director | S | 187,855 | 29.68 | $5,576,006 |
| 2026-03-20 | Pharmacy Investors, LLC | other | S | 827,636 | 29.68 | $24,566,306 |
| 2026-03-20 | Pharmacy Investors, LLC | other | S | 827,636 | 29.68 | $24,564,236 |
| 2026-03-20 | Burke Fred | director | S | 671,432 | 29.68 | $19,928,102 |
| 2026-03-20 | Morris David K | director | S | 187,855 | 29.68 | $5,575,536 |
| 2026-03-20 | Salentine Thomas J Jr | director | S | 3,570,677 | 29.68 | $105,977,693 |
| 2026-03-20 | Bindley Capital Partners I, LLC | ten percent owner | S | 3,570,677 | 29.68 | $105,977,693 |
| 2026-03-20 | Ackerman John | director | S | 275,728 | 29.68 | $8,183,607 |
| 2026-03-20 | Ackerman John | director | S | 827,636 | 29.68 | $24,564,236 |
| 2026-03-20 | BINDLEY WILLIAM E | director | S | 3,570,677 | 29.68 | $105,977,693 |
| 2026-03-20 | Forbes Kendall | officer | S | 346,672 | 29.68 | $10,289,225 |
| 2026-03-20 | Cardinal Equity Fund, L.P. | other | S | 275,728 | 29.68 | $8,183,607 |
| 2026-03-01 | Morris David K | director | A | 8,952 | 0 | $0 |
| 2026-03-01 | Forbes Kendall | officer | A | 8,952 | 0 | $0 |
| 2026-03-01 | Morris David K | director | A | 8,952 | 0 | $0 |
| 2026-03-01 | Forbes Kendall | officer | A | 8,952 | 0 | $0 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.